Vidia

en

  • Home
  • Monotests
  • ELISA+LIA
    • Infectious serology
      • Aspergillus fumigatus
      • Chlamydia spp
      • Borrelia spp
      • Herpesviruses
        • Human herpesvirus 6 (HHV 6)
        • Herpes simplex virus (HSV)
        • Epstein-Barr virus (EBV)
        • Human Cytomegalovirus (CMV)
        • Varicella zoster virus (VZV)
      • Mycoplasma pneumoniae
      • Polyomavirus
      • Pseudomonas aeruginosa
      • SARS-CoV-2
      • Tick borne encephalitis virus – TBEV
      • Tick season
      • Toxoplasma gondii
    • Autoantibodies
      • Vimentin
      • Complement factor H
    • Cytoskeleton
    • Antigens for complement fixation assay
      • Influenza
      • Adenovirus
    • Cytokines
    • Environmental monitoring
      • Bisphenol A
      • Microcystin-LR
    • Education
    • Automation
      • Vidimat
      • Monotests
  • Rapid tests
    • Mononucleosis
    • Diagnosis of gastro-intestinal infections
    • Diagnosis of respiratory infections
    • Inflammatory and tumor markers
  • E-Calculator
  • About us
    • Certificates
    • GDPR
    • Catalogue 2023
    • In Vitro Diagnostic Regulation (IVDR)
  • Contacts
joomla menu module not showing

VIDIA Ltd. - Czech IVD manufacturer

  • Analyser VIDIMAT

    More
  • Tick season
    Borrelia and TBEV tests
    More
  • Catalogue 2023
    Downolad the complete catalogue for 2023
    More
  • E-calculator
    Calculator for quantification using ELISA-VIDITEST kits
    More

Events and news

SARS-CoV-2

VIDIA spol s r.o. introduces new products SARS-CoV-2 for accurate antibodies and antigens detection.

See more ...

View a portfolio of diagnostic tests designed to detect SARS-CoV-2

Rapid-VIDITEST

VIDIA spol s r.o. brings a Rapid-VIDITEST for qualitative detection of SARS-CoV-2 antigens and for simultaneous detection of SARS-CoV-2 antigens and Influenza A and Influenza B virus antigens in human nasopharyngeal swab specimens.

See more ...

View a portfolio of diagnostic tests designed to detect SARS-CoV-2

Rapid-VIDITEST

VIDIA spol s r.o. offers a Rapid-VIDITEST for quantitative detection of IgG and IgM antibodies to SARS-CoV-2 in human whole whole blood, serum or plasma specimens.

See more ...

View a portfolio of diagnostic tests designed to detect SARS-CoV-2

ELISA-VIDITEST

VIDIA spol s r.o. offers a new generation of IVD serological kits ELISA-VIDITEST and MONO-VIDITEST for detection of antibodies against nucleocapsid proteine (NP) and separately protein Spike (S1) of the SARS-CoV-2.

See more ...

View a portfolio of diagnostic tests designed to detect SARS-CoV-2

SIC povinna publicita barevna EN
EU Operational programme
ministerstvo projekt
Copyright © 2023 Vidia. All Rights Reserved.